Ms. Andrea Young reports
MEDMIRA TO SUBMIT CUTTING-EDGE RAPID HIV TEST FOR WHO PREQUALIFICATION
MedMira Inc. will submit a new application for its most advanced Reveal rapid HIV
antibody test to the World Health Organization (WHO) prequalification of diagnostics
program. The latest version of Reveal HIV, recently approved in the
European Union, delivers faster and more convenient point-of-care
testing in the field through its simplified test procedure and the
direct use of whole-blood specimens. These new features are also in
the Reveal and Multiplo products currently being commercialized in
preparation for U.S. Food and Drug Administration submission.
The MedMira management team made the decision to submit its most
advanced Reveal HIV test to the WHO for prequalification based on the
company's commitment to offer state-of-the-art technology and testing
solutions to every corner of the world. Prequalification of the latest
Reveal HIV format will also enable MedMira's global strategic partners
to bring the best technology and products to all markets where care
providers and patients can benefit from faster, more cost-effective
testing solutions. As MedMira rolls out this advanced version of Reveal
HIV around the globe, legacy products will be phased out, and the
company will no longer support previous versions of the test, including
the format originally submitted to the WHO for prequalification.
"Health care providers around the world are demanding the most advanced
technology that qualified rapid test developers have to offer in order
to meet the increasing need for screening tools that help prevent and
control the spread of deadly diseases like HIV. By submitting Reveal
HIV, built on the latest advances in our Rapid vertical-flow
technology, for prequalification, MedMira is answering the WHO's call
for state-of-the-art, innovative products needed in their programs,"
said Hermes Chan, chief executive officer of MedMira.
Mr. Chan added: "Cost-efficiency combined with high-quality tests are
critical to all government and non-government organizations running
testing programs. MedMira is creating new modelling tools to help care
providers optimize their program outputs and maximize available
budgets, especially important in regions where large-scale screening
programs have the most impact. Our goal is to provide a comprehensive
testing solution that includes the most advanced diagnostic technology,
the highest-quality tests and optimization tools to save lives."
© 2024 Canjex Publishing Ltd. All rights reserved.